Vident Advisory, LLC

SEC CIK: 0001744347
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

FDMT holding history

4D Molecular Therapeutics, Inc. in every 13F filed by Vident Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FDMT overview All 13F holders of FDMT Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2023

Holdings of FDMT by Vident Advisory, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−8,600−100.0%	Sold out	Holders
Q1 2024	8,600	$274.0K	<0.1%	+8,600	New	Holders
Q4 2023	0	$0	0.0%	−10,574−100.0%	Sold out	Holders
Q3 2023	10,574	$134.6K	<0.1%	–	No prior filing	Holders